These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37516382)

  • 1. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: author's response.
    Mukaka M; Manesh A; Varghese GM
    Clin Microbiol Infect; 2023 Nov; 29(11):1463-1464. PubMed ID: 37516382
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: 'Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis' by Manesh et al.
    Muthu V; Agarwal R; Chakrabarti A
    Clin Microbiol Infect; 2023 Nov; 29(11):1461-1462. PubMed ID: 37473841
    [No Abstract]   [Full Text] [Related]  

  • 3. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study.
    Manesh A; Devasagayam E; Bhanuprasad K; Varghese L; Kurien R; Cherian LM; Dayanand D; George MM; Kumar SS; Karthik R; Vanjare H; Peter J; Michael JS; Thomas M; Mathew BS; Samuel P; Peerawaranun P; Mukaka M; Rupa V; Varghese GM
    Clin Microbiol Infect; 2023 Oct; 29(10):1298-1305. PubMed ID: 37348653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 associated rhino-orbital-cerebral mucormycosis-an institutional series.
    Naruka S; Rana N; Singh N; Kishore A; Nagpal K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):134S-144S. PubMed ID: 35176884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India.
    Taneja J; Chatterjee K; Sasidharan J; Abbas SZ; Rai AK; Raychaudhury S; Das B; Das A
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37442616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient.
    Ashkenazi-Hoffnung L; Bilavsky E; Avitzur Y; Amir J
    Transplantation; 2010 Nov; 90(10):1133-5. PubMed ID: 21427635
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
    Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
    Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis-An Exploratory Study.
    Dandu H; Kumar N; Kumar N; Malhotra HS; Prabhu V; Bharti VR; Gupta P; Yadav G; Verma V
    Mycopathologia; 2024 Jun; 189(4):54. PubMed ID: 38865003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amphotericin and posaconazole for gastrointestinal mucormycosis].
    Sanduende Otero Y; Moreno López E; Rodríguez Losada M; Roibal MA
    Rev Esp Anestesiol Reanim; 2009 Feb; 56(2):131-2. PubMed ID: 19334671
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhino-Orbito-Cerebral Mucormycosis in Diabetic Disease Mucormycosis in Diabetic Disease.
    Galletti B; Freni F; Meduri A; Oliverio GW; Signorino GA; Perroni P; Galletti C; Aragona P; Galletti F
    J Craniofac Surg; 2020 Jun; 31(4):e321-e324. PubMed ID: 32028364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
    Abboud CS; Bergamasco MD; Baía CE; Lallée MP; Zan AS; Zamorano MM; Pereira OI; Mies S
    Transplant Proc; 2012 Oct; 44(8):2501-2. PubMed ID: 23026630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.
    Pagano L; Cornely OA; Busca A; Caira M; Cesaro S; Gasbarrino C; Girmenia C; Heinz WJ; Herbrecht R; Lass-Flörl C; Nosari A; Potenza L; Racil Z; Rickerts V; Sheppard DC; Simon A; Ullmann AJ; Valentini CG; Vehreschild JJ; Candoni A; Vehreschild MJ
    Haematologica; 2013 Oct; 98(10):e127-30. PubMed ID: 23716556
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
    Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
    Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
    Salas V; Pastor FJ; Calvo E; Alvarez E; Sutton DA; Mayayo E; Fothergill AW; Rinaldi MG; Guarro J
    Antimicrob Agents Chemother; 2012 May; 56(5):2246-50. PubMed ID: 22290952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
    Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
    Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
    Murthy R; Bagchi A; Gote Y; Desai S
    Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.